Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Chronic Histological Changes in Renal Allograft
NCT01510795Phase 4Unknown
- Sponsor
- Clinical Hospital Merkur
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of spironolactone in Chronic Allograft Kidney Disease (CKaD), sponsored by Clinical Hospital Merkur. Status: unknown.
02
Drugs
spironolactone
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT01510795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510795.